PLI PLUS Title Details

Create Account
About PLI PLUS
Help
Contact Us

Questions? Comments?
Contact us.

Email: PLUS@pli.edu
Phone: 877.900.5291
PLI.edu
SIGN IN

Developments in Pharmaceutical and Biotech Patent Law 2018

Chair(s): Daniel L. Reisner
Practice Area: Intellectual Property
Published: Oct 2018
ISBN: 9781402432545
PLI Item #: 219403
CHB Spine #: G1389

This version is not current.
Click here for the most recent version.

Select All

Front Matter
Faculty Bios
Table of Contents
Chapter 1. IPRs: Oil States, SAS, and Other Developments
Chapter 2. Preliminary and Permanent Injunctions in Life Sciences Patent Litigation
Chapter 3. Patenting Biologics—Antibodies, Proteins and Cell-Based Therapies
Chapter 4. United States Patent and Trademark Office, Memorandum, Clarification of Written Description Guidance for Claims Drawn to Antibodies and Status of 2008 Training Materials (February 22, 2018); Subject Matter Eligibility Examples: Life Sciences; United States Patent and Trademark Office, Memorandum, Recent Subject Matter Eligibility Decision: Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals (June 7, 2018)
Chapter 5. Complaint for Patent Infringement, Amgen Inc. v. Apotex Inc. (S.D. Fla. Aug. 7, 2018)
Chapter 6. Actavis and “Reverse-Payment” Settlements of Hatch-Waxman Patent Litigation
Chapter 7. Sanjay K. Murthy and Maria E. Doukas, Ethical Issues Confronting Life Sciences Patent Lawyers
Index